| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Toru Nakai CEO | JPX Exchange | JP3717600005 ISIN |
| Japan Country | 2,243 Employees | 30 Sep 2026 Last Dividend | - Last Split | - IPO Date |
Nippon Shinyaku Co., Ltd. is a diversified company with a rich history dating back to 1911, engaged in the manufacturing and selling of pharmaceuticals and foodstuffs both in Japan and international markets. The company is segmented into two core operations: Pharmaceuticals and Functional Food Business. With its headquarters in Kyoto, Japan, Nippon Shinyaku Co., Ltd. has established itself as a key player in the production of innovative health products, driven by its dedication to addressing various medical and health needs across different demographics globally.
This sector of Nippon Shinyaku focuses on the development and distribution of drugs aimed at addressing a wide array of diseases. The portfolio includes treatments in areas such as urology, hematology, intractable and rare diseases, gynecology, among others. Leveraging advanced research and development capabilities, the company aims to provide effective solutions for patient care and enhance the quality of life for individuals suffering from various health conditions.
Nippon Shinyaku’s foray into the functional food sector underscores its commitment to preventive health and wellness. This segment produces a range of health food ingredients, preservatives, and protein preparations. Furthermore, the company caters to the growing demand for sports and dietary supplements, aligning with modern consumers' focus on health maintenance, performance optimization, and nutritional balance.